iScribe is a technology company.
iScribe has raised $36.0M across 2 funding rounds.
iScribe has raised $36.0M in total across 2 funding rounds.
iScribe is a Nashville-based technology company developing an AI-powered mobile app that automates clinical documentation for physicians. It integrates seamlessly with major electronic health record (EHR) systems like athenahealth, using speech-to-text and generative AI to generate notes in real-time during patient visits, including telehealth, reducing administrative burdens and enabling providers to focus on care.[1][2][3]
The product serves hospitals, health systems, ambulatory practices, and digital health providers, with strong traction in orthopedics. It solves physician burnout by saving up to 2 hours daily on documentation, accelerating billing and workflows without requiring new systems or lengthy setup—often deployable in a day. With 154 employees and revenue under $5 million, iScribe shows growth momentum, including selection as a top Southeast tech company in Venture Atlanta 2018.[1][2][3]
iScribe emerged from the need to address physician administrative overload, founded by co-founders including CEO & Co-Founder Pat Williams and COO & Co-Founder (name not specified in sources). Headquartered in Nashville, Tennessee, the company has built a team of 154 employees focused on healthcare software.[1][3][5]
Early recognition came in 2018 when iScribe was selected from hundreds of applicants as one of Venture Atlanta's top 34 rising star technology companies in the Southeast, highlighting its initial traction in streamlining EHR-integrated documentation.[1] Led by Pat Williams, the company has evolved to incorporate generative AI and ambient listening, gaining substantial adoption in orthopedic workflows.[2][5]
iScribe rides the AI ambient scribing trend in healthcare, where tools automate documentation amid clinician burnout rates exceeding 50% and EHR frustrations. Timing aligns with post-pandemic telehealth growth and AI advancements in natural language processing, enabling real-time transcription tailored to specialties like orthopedics.[2][3][5]
Market forces favor it: U.S. physician shortages, rising administrative costs (up to 2 hours daily per doctor), and EHR mandates create demand. iScribe influences the ecosystem by accelerating billing, authorizations, and patient focus, positioning it against competitors like DeepScribe and Suki while expanding integrations.[1][2]
iScribe is poised for expansion by deepening EHR partnerships and targeting high-burnout specialties beyond orthopedics. Trends like multimodal AI (voice + ambient) and value-based care will amplify its impact, potentially driving funding or acquisitions as health systems prioritize efficiency.[1][2][3]
Its influence may evolve into a broader workflow optimizer, helping providers "leave with their last patient" amid AI-healthcare convergence—reinforcing its core mission to restore doctor-patient relationships.[3][5]
iScribe has raised $36.0M in total across 2 funding rounds.
iScribe's investors include Galen Partners.
iScribe has raised $36.0M across 2 funding rounds. Most recently, it raised $15.0M Series D in April 2001.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2001 | $15.0M Series D | Galen Partners | |
| Mar 1, 2000 | $21.0M Series B | Galen Partners |